TBX1 and hematologic disorder: In light of this, we have summarized the activation of CAFs and the main molecular pathways through which they promote the progression of hematological malignancies (Figure 3), and compared the different roles played by CAFs in solid tumors and hematological malignancies (Figure 4) to make the research situation of CAFs in tumors more visually clear.